Improve Medical Instruments Co

Improve Medical Instruments Co Assets per Share

The Total Assets per Share of Improve Medical Instruments Co (300030.SZ) as of Nov 19, 2026 is 3.32 CNY. In the previous year, Total Assets per Share was 4.02 CNY — a change of -17.46% (lower).

Assets per Share

3.32CNY

YoY

-17.46%

Last updated:

Total Assets per Share of Improve Medical Instruments Co is 2025 3.32 CNY. Total Assets per Share of Improve Medical Instruments Co was 2024 4.02 CNY. It decreases by -17.46% lower compared to the previous year.

The Improve Medical Instruments Co Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
4.89 CNY
Jan 1, 2019
4.87 CNY
Jan 1, 2020
5.64 CNY
Jan 1, 2021
5.90 CNY
Jan 1, 2022
5.04 CNY
Jan 1, 2023
4.61 CNY
Jan 1, 2024
4.02 CNY
Jan 1, 2025
3.32 CNY
The Improve Medical Instruments Co Assets per Share history
YEARAssets per ShareYoY
3.32CNY-17.46%
4.02CNY-12.75%
4.61CNY-8.49%
5.04CNY-14.62%
5.90CNY+4.60%
5.64CNY+15.79%
4.87CNY-0.29%
4.89CNY-13.44%
5.65CNY+18.78%
4.75CNY+2.12%
4.66CNY+41.20%
3.30CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Improve Medical Instruments Co Stock analysis

What does Improve Medical Instruments Co do? Improve Medical Instruments Co., Ltd. generates revenue through clinical care services, testing laboratory operations, and financial leasing of medical equipment. The company sells vacuum blood collection systems, liquid biopsy tubes, automatic blood collection tube detachers, thromboelastometers, reagents, hospital intelligent blood collection management systems, and sub-medical record systems (EMR). Its products are exported to Russia, Saudi Arabia, Brazil, and South Korea, with additional offerings including masks, instruments, and reagents. The firm serves healthcare providers and medical facilities globally through these product lines and services. The company's revenue streams include the sale of medical equipment and related products, as well as financial leasing services for medical devices. Products like vacuum blood collection systems and hospital management systems target hospitals and laboratories, while exports to countries such as Russia and Brazil indicate a focus on international markets. The firm's product portfolio spans diagnostic tools, blood collection solutions, and EMR systems, catering to diverse healthcare needs. Improve Medical Instruments Co., Ltd. provides clinical care and testing laboratory services alongside product sales, with a strong emphasis on exporting medical equipment and reagents. The firm's export markets include Russia, Saudi Arabia, Brazil, and South Korea, where its vacuum blood collection systems, thromboelastometers, and EMR systems are in demand. Revenue is derived from both direct product sales and financial leasing of medical equipment to healthcare institutions. Improve Medical Instruments Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Improve Medical Instruments Co stock

Total Assets per Share of Improve Medical Instruments Co is 3.32 CNY in 2025.

Total Assets per Share of Improve Medical Instruments Co changed from 4.02 CNY to 3.32 CNY, representing a -17.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Improve Medical Instruments Co since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Improve Medical Instruments Co

All Key Metrics — Improve Medical Instruments Co